Ledger.Open graph →
SEC Form D · filed June 23, 2020

Cardiff Oncology, Inc

Offering
$13.5M
Sold
$13.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

John W. Brancaccio · San Diego, CADirectorLale O. White · San Diego, CADirectorThomas H. Adams · San Diego, CADirectorGary W. Pace · San Diego, CADirectorRodney S. Markin · San Diego, CADirectorMark S. Erlander · San Diego, CAExec · DirectorJames O. Armitage · San Diego, CADirectorGary S. Jacob · San Diego, CADirectorPaul Kaju · Grand Cayman, Cayman IslandsDirectorPeter Huber · Grand Cayman, Cayman IslandsDirectorAlan Spragins · Seattle, WADirectorIan Muhammad Charoub · Senningerberg, LuxembourgDirectorGanash M. Lokanathen · Senningerberg, LuxembourgExec · DirectorJoseph Schocken · SEATTLE, WADirectorWilhelmina Steenis · Senningerberg, LuxembourgDirectorJohn Tomizuka · SEATTLE, WADirectorRay A. Sturm · San Francisco, CADirectorRobert D. Jennings · Cincinnati, OHDirectorHarry J. Hanchar · Pittsburgh, PADirectorJeremy Powell · Jacksonville, FLDirectorJohn A. Switzer · Charlotte, NCExec · DirectorDavid A. Mihalick · Charlotte, NCDirectorClarendon H. Masters · Pembroke, BermudaDirectorJin W. Lee · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗